EU pays $74M to U.S. drugmaker for remdesivir COVID-19 treatment
Wednesday, July 29, 2020 - 09:30
in Mathematics & Economics
The European Union said Wednesday it will pay $74 million to a U.S. drugmaker for doses of remdesivir to fight COVID-19.